In This Article:
In the last week, the United States market has stayed flat, yet it is up 24% over the past year with earnings forecasted to grow by 15% annually. In this context, identifying small-cap stocks with insider action can be an intriguing strategy for investors seeking potentially undervalued opportunities amidst stable market conditions.
Top 10 Undervalued Small Caps With Insider Buying In The United States
| Name | PE | PS | Discount to Fair Value | Value Rating |
|---|---|---|---|---|
| ProPetro Holding | NA | 0.7x | 22.27% | ★★★★★☆ |
| OptimizeRx | NA | 1.1x | 43.45% | ★★★★★☆ |
| Quanex Building Products | 32.1x | 0.8x | 40.10% | ★★★★☆☆ |
| First United | 12.9x | 2.9x | 47.11% | ★★★★☆☆ |
| McEwen Mining | 4.1x | 2.1x | 46.58% | ★★★★☆☆ |
| Innovex International | 8.8x | 2.0x | 49.92% | ★★★★☆☆ |
| German American Bancorp | 14.8x | 4.9x | 48.28% | ★★★☆☆☆ |
| Franklin Financial Services | 10.4x | 2.0x | 33.63% | ★★★☆☆☆ |
| Delek US Holdings | NA | 0.1x | -72.89% | ★★★☆☆☆ |
| Sabre | NA | 0.4x | -35.48% | ★★★☆☆☆ |
Here we highlight a subset of our preferred stocks from the screener.
Semler Scientific
Simply Wall St Value Rating: ★★★★☆☆
Overview: Semler Scientific specializes in developing and marketing diagnostic kits and equipment, with a market capitalization of approximately $0.21 billion.
Operations: The company generates revenue primarily from diagnostic kits and equipment, with a recent gross profit margin of 88.05%. Operating expenses are significant, with sales and marketing expenses being the largest component. Net income margin has shown fluctuations, most recently recorded at 27.00%.
PE: 30.5x
Semler Scientific, a small-cap company in the U.S., recently completed an $85 million fixed-income offering with convertible notes due in 2030. Despite volatile share prices and reliance on external borrowing, they show insider confidence through recent purchases. Earnings have been stable, with third-quarter net income at US$5.61 million compared to US$5.51 million last year, although revenue decreased to US$13.51 million from US$16.32 million. Future earnings are projected to decline annually by 5.6% over the next three years, highlighting potential challenges amidst its undervalued status.
-
Navigate through the intricacies of Semler Scientific with our comprehensive valuation report here.
-
Understand Semler Scientific's track record by examining our Past report.
Myers Industries
Simply Wall St Value Rating: ★★★☆☆☆
Overview: Myers Industries is a diversified manufacturing and distribution company primarily focused on material handling and distribution products, with a market cap of approximately $0.85 billion.
Operations: The company generates revenue primarily through its Material Handling and Distribution segments, with the former contributing significantly more. Over recent periods, the gross profit margin has shown a trend of fluctuation, reaching 32.34% in September 2024. Operating expenses have been a consistent part of the cost structure, impacting net income margins which varied notably over time.